首页> 美国卫生研究院文献>Journal of Clinical Oncology >Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

【2h】

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

机译：高剂量低剂量质子束治疗局部不可切除的肝细胞癌和肝内胆管癌的多机构II期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeTo evaluate the efficacy and safety of high-dose, hypofractionated proton beam therapy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).

机译：目的评估大剂量，超分割质子束治疗肝细胞癌（HCC）和肝内胆管癌（ICC）的疗效和安全性。

著录项

期刊名称 Journal of Clinical Oncology
作者
Theodore S. Hong; Jennifer Y. Wo; Beow Y. Yeap; Edgar Ben-Josef; Erin I. McDonnell; Lawrence S. Blaszkowsky; Eunice L. Kwak; Jill N. Allen; Jeffrey W. Clark; Lipika Goyal; Janet E. Murphy; Milind M. Javle; John A. Wolfgang; Lorraine C. Drapek; Ronald S. Arellano; Harvey J. Mamon; John T. Mullen; Sam S. Yoon; Kenneth K. Tanabe; Cristina R. Ferrone; David P. Ryan; Thomas F. DeLaney; Christopher H. Crane; Andrew X. Zhu;
展开▼
作者单位

展开▼
年(卷),期 -1(34),5
年度 -1
页码 460–468
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [J] . Hong Theodore S., Wo Jennifer Y., Yeap Beow Y., Journal of Clinical Oncology . 2016,第5期

机译：高剂量低分割质子束治疗局部，不可切除的肝细胞癌和肝内胆管癌的多机构II期研究
2. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [J] . Hong Theodore S., Wo Jennifer Y., Yeap Beow Y., Journal of Clinical Oncology . 2016,第5期

机译：局部，不可切除的肝细胞癌和肝内胆管癌患者高剂量低频分频质子束治疗的多机构期II研究
3. Hepatocyte Growth Factor is Associated With Liver Dysfunction and Survival: Biomarker Results of a Phase 2 Study of Proton Beam Therapy in Patients with Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [J] . Hong T. S., Grassberger C., Yeap B. Y., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：肝细胞生长因子与肝功能障碍和存活相关：生物标志物的肝细胞癌和肝内胆管癌患者的质子束治疗的2阶段研究
4. Deep Convolutional Neural Network for the Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [C] . Abhishck Midya, Jayasree Chakraborty, Linda M. Pak, SPIE Medical Imaging Conference . 2018

机译：深度卷积神经网络用于肝细胞癌和肝内胆管癌的分类
5. Transient increases in serum α fetoprotein and protein induced by vitamin K antagonist II levels following proton therapy does not necessarily indicate progression of hepatocellular carcinoma [D] . YOSHIDA MAIKO, 吉田舞子 2019

机译：质子治疗后血清α甲胎蛋白和维生素K拮抗剂II水平诱导的蛋白的短暂增加不一定表明肝细胞癌的进展
6. Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma [O] . Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, 2020

机译：超分割质子束治疗肝细胞癌的II期研究
7. Treatment-Induced Changes in Circulating Lymphocyte Populations Associate With Survival of Patients With Hepatocellular Carcinoma (HCC) and Intrahepatic Cholangiocarcinoma (ICC) Treated With Hypofractionated Proton Therapy (HPT) [O] . C. Grassberger, J.Y. Wo, T. Hato, 2016

机译：循环淋巴细胞群体的治疗诱导的变化与肝细胞癌（HCC）患者的存活和用次乳化物质疗法治疗（HPT）治疗的肝内胆碱和肝内胆管癌（ICC）

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅